8-KLeadership ChangesCorporate ChangesExhibits & Filings

THERMO FISHER SCIENTIFIC INC. 8-K Report, Executive Changes (Jul 14, 2011)

Filed July 14, 2011For Securities:TMO

Summary

This Form 8-K filing by Thermo Fisher Scientific Inc. (TMO) on July 13, 2011, primarily reports two significant corporate governance changes. Firstly, Lars Rebien Sørensen, President and CEO of Novo Nordisk A/S, was elected to the company's Board of Directors, effective July 12, 2011. He has also been appointed to the Corporate Social Responsibility Committee, bringing valuable experience from a leading global healthcare company. Secondly, the company's Board of Directors approved amendments to its bylaws, effective July 12, 2011, to eliminate the classified board structure. This means the board will transition to all directors being elected annually, with the full transition for all directors to be up for annual election completed by the 2014 annual meeting. This move towards annual elections for all directors and the possibility of removal by stockholders represents a significant shift in corporate governance, potentially increasing accountability to shareholders.

Key Highlights

  • 1Lars Rebien Sørensen, CEO of Novo Nordisk A/S, appointed to Thermo Fisher Scientific's Board of Directors.
  • 2Mr. Sørensen also appointed to the Board's Corporate Social Responsibility Committee.
  • 3Thermo Fisher Scientific's Board of Directors has voted to eliminate the classified board structure.
  • 4The declassification of the board means all directors will be up for annual election.
  • 5The transition to a fully declassified board will be completed by the 2014 annual meeting.
  • 6Directors can now be removed by stockholders with or without cause.
  • 7New directors elected after July 12, 2011, will serve terms expiring at the next annual stockholders' meeting.

Frequently Asked Questions

Lars Rebien Sørensen is the President and Chief Executive Officer of Novo Nordisk A/S, a major global healthcare company. His appointment to Thermo Fisher Scientific's Board of Directors on July 12, 2011, brings extensive leadership experience from the healthcare industry. He was also appointed to the Corporate Social Responsibility Committee.

A classified board, also known as a staggered board, divides directors into groups (classes), with only one class up for election each year. This structure can make it harder for shareholders to replace the entire board at once. Eliminating the classified board means all directors will be elected annually, increasing shareholder influence and potentially making the board more responsive to shareholder concerns.

The bylaws were amended effective July 12, 2011, to eliminate the classified board. However, the transition will not shorten the term of incumbent directors. All directors will be up for election annually beginning with the 2014 annual meeting.

Yes, the amended bylaws provide that directors are subject to removal by the stockholders with or without cause, effective from July 12, 2011.